Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/26 18:17 | 2/8/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | 1 | M.d | 0 | 0.00 | 0 | 16 | 2 | 846 | D | |||||||||||||||
2/10/26 18:16 | 2/7/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Spitznagel Thomas | MD | O | SVP,Tech | 1 | M.dm | 0 | 0.00 | 0 | 15 | 95 | 31 | D | ||||||||||||||
2/10/26 18:16 | 2/7/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Smith Beth Ann | MD | O | VP,Contr | 1 | M.dm | 0 | 0.00 | 0 | 4 | 53 | 12 | D | ||||||||||||||
2/10/26 18:15 | 2/7/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Risser Eric Blasius | MD | DO | P ,CEO | 1 | M.dm | 0 | 0.00 | 0 | 18 | 36 | 67 | D | ||||||||||||||
2/10/26 18:15 | 2/7/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Peters Jeffrey Stuart | MD | O | SVP,GC,, | 1 | M.dm | 0 | 0.00 | 0 | 15 | 189 | 23 | D | ||||||||||||||
2/10/26 18:14 | 2/7/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Karrels James | MD | O | SVP,CFO | 1 | M.dm | 0 | 0.00 | 0 | 16 | 9 | 197 | D | ||||||||||||||
2/10/26 18:13 | 2/7/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Bonvini Ezio | MD | O | SVP,Rese | 1 | M.dm | 0 | 0.00 | 0 | 18 | 15 | 136 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |